CME Group Inc.
CME
266.3
USD+3.03
(+1.15%)Day's range
261.3
266.46
52 wk Range
190.7
273.42
Key ratios
Statements Highlights
| Period Ending | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 | Dec 31, 2023 | Dec 31, 2024 | |
|---|---|---|---|---|---|---|
| Total Revenue | 4,883,600,000 | 4,689,700,000 | 5,019,400,000 | 5,578,900,000 | 6,130,100,000 | |
| Gross Profit | 4,027,100,000 | 3,852,700,000 | 4,266,300,000 | 4,750,300,000 | 5,279,800,000 | |
| Operating Income | 2,637,400,000 | 2,645,200,000 | 3,015,900,000 | 3,435,700,000 | 3,931,500,000 | |
| Net Income | 2,105,200,000 | 2,636,400,000 | 2,691,000,000 | 3,226,200,000 | 3,525,800,000 | |
| Total Assets | 124,659,600,000 | 196,780,300,000 | 174,175,700,000 | 129,706,100,000 | 137,447,000,000 | |
| Total Current Liabilities | 88,197,900,000 | 160,398,400,000 | 137,687,500,000 | 93,416,900,000 | 102,313,900,000 | |
| Total Equity | 26,351,500,000 | 28,470,200,000 | 28,005,500,000 | 26,737,900,000 | 26,486,900,000 | |
| Free Cash Flow | 2,518,100,000 | 2,275,200,000 | 2,966,300,000 | 3,377,400,000 | 3,690,500,000 | |
| Cash from Operations | 2,715,600,000 | 2,402,400,000 | 3,056,000,000 | 3,453,800,000 | 3,690,500,000 | |
| Cash from Investing | -175,500,000 | 58,400,000 | -489,800,000 | 20,900,000 | -82,600,000 | |
| Cash from Financing | -2,458,200,000 | 69,908,700,000 | -25,381,700,000 | -48,339,300,000 | 5,076,500,000 | |
| Net Change in Cash | 81,900,000 | 72,369,500,000 | -22,815,500,000 | -44,864,600,000 | 8,684,400,000 |
Dividends
Analyst Recomendations
Overall consensus
Buy